Itraconazole 130 Mg Supra-Bioavailable Capsule – CONTREX 130 SB

Itraconazole 130mg Supra-Bioavailable Capsules – Enhanced Absorption for Superior Antifungal Efficacy.

CONTREX 130 SB: The composition of Itraconazole 130 mg Supra-Bioavailable Capsules is a triazole antifungal that works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, leading to fungal cell death. The supra bioavailable formulation enhances absorption and therapeutic efficacy at lower doses, making it more effective and patient-friendly. It is indicated for both superficial and systemic fungal infections.

Recommended BY Specialists:
General Physicians: It is preferred to treat the disease associated with common fungal infections requiring oral antifungal therapy
Pulmonologists –It is preferred to treat the disease associated with fungal lung infections (aspergillosis, histoplasmosis).
Infectious Disease Specialists –Treating the disease associated with systemic fungal infections is preferred.

Key Benefits of Itraconazole 130 mg Supra-Bioavailable Capsule – CONTREX 130 SB:
Improved Bioavailability: Supra bioavailable formulation ensures higher absorption and consistent therapeutic levels with lower doses than conventional itraconazole formulations.
Broad-Spectrum Antifungal Action: Effective against various fungal infections, including systemic and superficial mycoses.
Reduced Gastrointestinal Side Effects: Optimized formulation enhances patient compliance by minimizing GI discomfort.

INDICATIONS:
Systemic fungal infections (e.g., aspergillosis, histoplasmosis).
Dermatophytic infections (e.g., tinea corporis, tinea pedis).
Onychomycosis (fungal nail infections).
Candidiasis (oral, esophageal, or vulvovaginal).
Pityriasis versicolor.